Our study suggested the RIG-I signaling pathway, as a novel signaling target of PNS, mediated anti-inflammatory properties of PNS in cerebral ischemia, which supported the use of PNS in clinic for anti-inflammation in ischemic diseases. This evidence concerns the gene RIGI and ischemic disease.